ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Scientists have successfully immortalized lip cells, creating a clinically relevant lab model that enables testing of new ...

Transgene, ProBioGen join forces to advance individualized cancer vaccine development: Strasbourg, France Thursday, November 7, 2024, 11:00 Hrs [IST] Transgene, a biotech company ...

Engineering immune cells to fight a rare form of skin cancer The Chapuis Lab focuses on T-cell receptor (TCR ... The project ...

a protein involved in pancreatic cancer ... DNA Packaging Directly Affects How Fast DNA Is Copied in Cells Nov. 12, 2024 — Researchers have found that the way DNA is packaged in cells can ...

This allows targeting the immune activation to tumors, increasing both efficacy and safety and opening up new opportunities for cancer treatment. T cell engagers (TCE) are a powerful class of immuno .

Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

Penn Ovarian Cancer Research Center and Basser Center for BRCA, University of Pennsylvania, Perelman School of Medicine, Philadelphia, United States ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...

Transcription activation of genes by estrogens is driven by enhancers, which are often located within the same Topologically Associating Domain (TAD) as non-targeted promoters. We investigated how ...